Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,701.53 today based on a price of $771.99 for LLY at the time of writing.

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Eli Lilly’s blockbuster GLP-1 drugs dominate headlines, but its broader portfolio deserves a standing ovation for driving ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

Although I don't expect AbbVie, Lilly, and J&J to crash, the unanswered questions relating to tariffs and international reference pricing could weigh on all three big pharma stocks.

Indeed, shares of the three biggest pharmaceutical companies based on market cap -- AbbVie (ABBV -0.93%), Eli Lilly (LLY 0.16%), and Johnson & Johnson (JNJ 0.24%) -- have all delivered solid gains ...

Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products in the U.S., they still import some drugs and ingredients used in the products.